Millenco reports 4% stake in Critical Therapeutics

By Angela McDaniels

Tacoma, Wash., March 13 - Investors led by Millenco LLC reported the purchase of 193,065 shares of Critical Therapeutics, Inc. common stock in a schedule 13D filing with the Securities and Exchange Commission.

The shares were purchased between Jan. 11 and March 11 for $0.91 to $1.34 each.

During the same period, the investors sold 483,440 shares for $0.90 to $1.43 each.

The investors beneficially own 1,718,250 shares, or 4%, of the Lexington, Mass.-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.